Trade ShockWave Medical, Inc. - SWAV CFD

ShockWave Medical, Inc. Company profile

About Shockwave Medical Inc

Shockwave Medical, Inc. is a medical device company. The Company is engaged in medical device treatment of atherosclerotic cardiovascular disease (atherosclerosis) through its differentiated local delivery of sonic pressure waves for the treatment of calcified plaque, which refer to as intravascular lithotripsy (IVL). Its products for the treatment of peripheral artery disease (PAD) includes Shockwave M5 IVL catheter (M5 catheter) and Shockwave S4 IVL catheter (S4 catheter). Its product for the treatment of coronary artery disease (CAD) is Shockwave C2 IVL catheter (C2 catheter). M5 catheter is a five-emitter catheter for use in its IVL System in medium vessels for the treatment of above-the-knee PAD. S4 catheter is a four-emitter catheter for use in its IVL System in small vessels for the treatment of below-the-knee PAD. C2 catheter is a two-emitter catheter for use in its IVL System for the treatment of CAD.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Shockwave Medical Inc revenues increased from $67.8M to $237.1M. Net loss decreased 86% to $9.1M. Revenues reflect United States segment increase from $37.1M to $186.3M, Rest of Europe segment increase from $19.1M to $38.6M. Lower net loss reflects Interest Expense decrease of 10% to $1.1M (expense). Basic Earnings per Share excluding Extraordinary Items increased from -$1.99 to -$0.26.